Nasdaq

Invitae Launches Update to Invitae Generation™: Clinical Variant Modeling Improves Variant Classification

SAN FRANCISCO, March 12, 2024 /PRNewswire/ -- Invitae (OTC: NVTA), a leading medical genetics company, today announced the launch of an update to Invitae Generation™ with Clinical Variant Modeling, a ...
Nasdaq

Invitae to Present Data at the 2024 ACMG Annual Clinical Genetics Meeting

SAN FRANCISCO, March 5, 2024 /PRNewswire/ -- Researchers from Invitae (OTC: NVTA), a leading medical genetics company, are showcasing their work next week at the 2024 American College of Medical ...
ksn.com

Landmark Study Reveals Magnitude of Uncertain Results in Clinical Genetic Testing for Hereditary Disease, Points to Evidence-Based Solutions to Reach Definitive Results

– Findings set to enhance patient care and reduce uncertainty in test results as clinicians advance precision healthcare for hereditary disease – "Uncertainty in genetic testing is frustrating for ...